Fundz

Nuo Therapeutics, Inc. reported raising $3.55 Million in an initial SEC Form D filing, from an offering of $3.55 Million

PUBLIC · AURXMay 06, 2022

Amount Raised

$3.55 Million

$3.55 Million sold, per SEC Form D (first sale May 6, 2022)

Round Type

Venture

HoustonBiotechnologyHealthcareHealth Care

Who to call at Nuo Therapeutics, and when

A new round usually means Nuo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nuo Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nuo Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nuo Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nuo Therapeutics

Location

8285 El Rio

Houston, Texas, United States

About

Nuo Therapeutics, Inc. is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing. The Company’s flagship product, Aurix is a biodynamic hematogel derived from the patient’s own platelets and plasma, which is used at the point-of-care to jumpstart the natural healing process in a broad range of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure injuries.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nuo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts17 people are listed at Nuo Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Nuo Therapeutics's next move

See what Strategic adds

Nuo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.